Clinical Trial

Impact of Low Dose Epinephrine in the Management of Out-of-hospital Cardiac Arrest on Neurological Outcome

Study acronym: Low-EPI
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study will test whether a lower dose of epinephrine (0.5 mg) given during emergency treatment for out-of-hospital cardiac arrest helps more patients survive with good brain function, compared to the standard dose (1 mg). Adults who experience cardiac arrest outside the hospital and are treated by emergency medical teams will be randomly assigned to receive either the low dose or the standard dose of epinephrine. The study will compare survival and neurological outcomes between the two groups over 28 days.
Trial Details
NCT Number NCT07442071
Lead Sponsor Central Hospital, Nancy, France
Conditions Out-of-hospital Cardiac Arrest (OHCA)
Enrollment 4,336 participants
Start Date 2026-06
Primary Completion 2030-07 (estimated)
Study Completion 2030-07 (estimated)
Updated on ClinicalTrials.gov 2026-03-02